| Product Code: ETC7635998 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Oncology NGS Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Oncology NGS Market - Industry Life Cycle |
3.4 Ireland Oncology NGS Market - Porter's Five Forces |
3.5 Ireland Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Ireland Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Ireland Oncology NGS Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.8 Ireland Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.9 Ireland Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Ireland Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Ireland |
4.2.2 Technological advancements in Next-Generation Sequencing (NGS) for oncology |
4.2.3 Rising demand for personalized medicine in cancer treatment |
4.3 Market Restraints |
4.3.1 High cost associated with NGS testing |
4.3.2 Limited reimbursement policies for NGS testing in oncology |
4.3.3 Data privacy and security concerns related to genomic data in Ireland |
5 Ireland Oncology NGS Market Trends |
6 Ireland Oncology NGS Market, By Types |
6.1 Ireland Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Ireland Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Ireland Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Ireland Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.2 Ireland Oncology NGS Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Ireland Oncology NGS Market Revenues & Volume, By Diagnostics and Screening, 2021- 2031F |
6.2.3 Ireland Oncology NGS Market Revenues & Volume, By Research Studies, 2021- 2031F |
6.3 Ireland Oncology NGS Market, By Service |
6.3.1 Overview and Analysis |
6.3.2 Ireland Oncology NGS Market Revenues & Volume, By Platforms and Related Products, 2021- 2031F |
6.3.3 Ireland Oncology NGS Market Revenues & Volume, By Services, 2021- 2031F |
6.4 Ireland Oncology NGS Market, By Workflow |
6.4.1 Overview and Analysis |
6.4.2 Ireland Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.4.3 Ireland Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.4.4 Ireland Oncology NGS Market Revenues & Volume, By NGS Data Analysis, 2021- 2031F |
6.5 Ireland Oncology NGS Market, By End-use |
6.5.1 Overview and Analysis |
6.5.2 Ireland Oncology NGS Market Revenues & Volume, By Academic Research, 2021- 2031F |
6.5.3 Ireland Oncology NGS Market Revenues & Volume, By Clinical Research, 2021- 2031F |
6.5.4 Ireland Oncology NGS Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F |
6.5.5 Ireland Oncology NGS Market Revenues & Volume, By Pharma & Biotech Entities, 2021- 2031F |
6.5.6 Ireland Oncology NGS Market Revenues & Volume, By Other users, 2021- 2031F |
7 Ireland Oncology NGS Market Import-Export Trade Statistics |
7.1 Ireland Oncology NGS Market Export to Major Countries |
7.2 Ireland Oncology NGS Market Imports from Major Countries |
8 Ireland Oncology NGS Market Key Performance Indicators |
8.1 Adoption rate of NGS testing in oncology clinics |
8.2 Number of clinical trials utilizing NGS technology in cancer research |
8.3 Rate of integration of NGS results into oncology treatment protocols |
9 Ireland Oncology NGS Market - Opportunity Assessment |
9.1 Ireland Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Ireland Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Ireland Oncology NGS Market Opportunity Assessment, By Service, 2021 & 2031F |
9.4 Ireland Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.5 Ireland Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Ireland Oncology NGS Market - Competitive Landscape |
10.1 Ireland Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Ireland Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here